Clinical Trial Update: Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis [Phase 3]

View source ↗

Summary

Phase III trial evaluating Vaccae™ for prevention of tuberculosis has completed; the update does not include specific efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Vaccae™

Snippet

Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Conditions: Tuberculosis | Phase 3 | Status: COMPLETED